Ultragenyx Unveils Exciting Progress in Pivotal Phase 1-2-3 Cyprus2 Study for Wilson Disease Treatment with UX701 Gene Therapy

Exciting Developments in Gene Therapy: Ultragenyx’s UX701 Shows Promise Introduction NOVATO, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) recently announced the positive results from the Phase 1/2/3 Cyprus 2+ study of its UX701 gene therapy. The study has shown significant clinical improvements and benefits in copper metabolism in Stage 1,…

Read More

Suncor Strikes a Deal: Tender Offers for Select Notes Priced to Perfection

Suncor Energy Inc. Announces Tender Offers Calgary, Alberta–(Newsfile Corp. – October 3, 2024) – Suncor Energy Inc. (TSX: SU) (NYSE: SU) Suncor’s Tender Offers Details Suncor Energy Inc. announced today the total consideration payable in connection with its previously announced tender offers (the “Tender Offers”) to purchase for cash: (i) up to C$1,000,000,000 aggregate principal…

Read More

James Bay Resources Limited: A Bittersweet Closure and Legal Action Against Wynn Resorts Ltd.

James Bay Resources Limited Announces Close of Second Tranche of Convertible Debenture Offering Toronto, Ontario–(Newsfile Corp. – October 3, 2024) Introduction James Bay Resources Limited (CSE: JBR) (“James Bay” or the “Company”) has recently announced the closing of its second tranche of a non-brokered private placement offering of unsecured convertible debentures. The Company has successfully…

Read More

Breaking News: Trevi Therapeutics Shares Exciting Update on Haduvio’s Clinical Development Program

Exciting Updates from Trevi Therapeutics, Inc. Phase 2b CORAL Trial Reaches 50% Enrollment Milestone The Phase 2b CORAL trial in idiopathic pulmonary fibrosis (IPF) chronic cough has reached a significant milestone, with 50% of the participants now enrolled. This is a promising development as the trial progresses towards its completion. The sample size re-estimation results…

Read More

TeraWulf Monetizes Equity Interests in Nautilus Joint Venture to Fuel Expansion of HPC, AI, and Bitcoin Mining at Flagship Lake Mariner Facility

TeraWulf Inc. Completes Sale of 25% Equity Interest in Nautilus Cryptomine Joint Venture Total Consideration of Approximately $92 Million Resulting in a 3.4x Return on Investment TeraWulf Inc. (Nasdaq: WULF) has announced the completion of the sale of its 25% equity interest in the Nautilus Cryptomine joint venture to a subsidiary of Talen Energy Corporation…

Read More

Get Ready to Laugh and Learn: First Interstate BancSystem Inc. Shares Q3 Earnings and Chit-Chats with Investors!

Welcome to the Quirky Corner! Get Ready for Some Banking Shenanigans! Hey there, fellow money-savvy readers! Today, I have some exciting news to share with you all. Brace yourselves, because First Interstate BancSystem, Inc., the parent company of First Interstate Bank, is gearing up to report their third-quarter results. Can I get a drum roll,…

Read More

Join Us at the H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference with Vir Biotechnology!

Join Us at the H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference with Vir Biotechnology! Description: SAN FRANCISCO–(BUSINESS WIRE)–Vir Biotechnology, Inc. (NASDAQ:VIR) today announced that Mark Eisner, M.D., M.P.H., Executive Vice President and Chief Medical Officer, is scheduled to participate in a fireside chat at the H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference on…

Read More

Power Restored to 90% of Georgia Power Customers Affected by Hurricane Helene: A Bright Update!

Power Restored to 90% of Georgia Power Customers Affected by Hurricane Helene: A Bright Update! Over 1.2 Million Customers Reconnected It’s always a relief to hear good news after a natural disaster strikes, and Georgia Power is providing just that. Following the most destructive storm in the company’s history, Hurricane Helene, over 1.2 million customers…

Read More